1 / 13

Anastrozole tablets market | Coherent Market Insights

According to Coherent Market Insights,North America accounted for the largest share in the anastrozole tablets market, followed by Europe in 2019, owing to increasing product launches.

shrutiCMI
Download Presentation

Anastrozole tablets market | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. ANASTROZOLE TABLETS MARKET ANALYSIS AnastrozoleTablets Market,ByType (Branded Anastrozole Tablets and Generic Anastrozole Tablets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027.

  3. The anastrozole tablets market is estimated to be valued at US$ 278.1 million in 2020 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027) Drivers • The increasing prevalence of breast cancer in women is expected to significantly contribute to growth of the anastrozole tablets market growth over the forecast period. For instance, according to the World Cancer Research Fund (WCRF) report of 2018, breast cancer is the most commonly occurring cancer in women and the second most common cancer globally. There were over 2 million new cases in 2018, globally. Furthermore, according to the World Health Organization (WHO) report of 2018, it is estimated that 627,000 women died from breast cancer in 2018, worldwide.

  4. Major players in the market are focused on launching anastrozole tablets in the market at low cost to gain maximum market share, which is expected to drive the anastrozole tablets market growth. For instance, in December 2013, Eli Lilly and Company, India announced that it launched four generic cancer drugs to treat patients with breast and colorectal cancer, respectively in India. The company launched four new drugs, Lilbecep (Epirubicin), Lilmantro (Anastrozole), Lilxapla (Oxaliplatin), and Lilrincan (Irinotecan), for the treatment of patients with breast cancer and colorectal cancer, respectively.

  5. Figure 1.Anastrozole Tablets Market Share(%) Analysis,By Type,2019

  6. MarketRestraints However, anastrozole tablets market growth is expected to hamper over the forecast period, owing to frequent drug recalls. For instance, in May 2019, Zydus Pharmaceuticals USA Inc. announced that it voluntarily recalled multiple lots of anastrozole tablets (1mg) at retail level. The product is under investigation by the U.S. FDA. The reason of drug recall was cross contamination due to a GMP cleaning procedure failure in the fluid bed dry processor area during the manufacturing time. Zydus Pharmaceuticals USA Inc. advised all the distributors to stop dispensing, which rapidly impeded growth of the anastrozole tablets market in 2019.

  7. Regional Analysis • North America accounted for the largest share in the anastrozole tablets market, followed by Europe in 2019, owing to increasing product launches.Forinstance, in February 2012,AstraZeneca Plc launched its first-ever direct-to-patient program offered to those with a valid prescription for breast cancer drug Arimidex (anastrozole) through a specialty pharmacy services provider in the U.S.,forUS$ 40 per month. • Furthermore, increasing launch of anastrozole tablets is also expected to boost the anastrozole tablets market growth in Asia Pacific in the near future.Forinstance,inSeptember 2019,Cooper Pharma,apharmaceutical manufacturing company specialized in generics/hormonal medications, announced that one of its wholly owned hormone product ANAZBOL was launched in New Delhi,India. The company is also set to launch ANAZBOL in 25 other countries with legal authorization.

  8. Figure 2.Anastrozole Tablets Market Value (US$ Mn) & Y-o-Y Growth (%),2017-2027

  9. Competitive Section Key players operating in the anastrozole tablets market include AstraZeneca Plc, Zydus Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, NatcoPharma, Fresenius Kabi, Accord Healthcare Ltd., Mylan N.V., Cipla Ltd., Apotex Inc., Zhejiang Hisun, Chongqing Huapont Pharmaceutical Co., Ltd., Zhejiang Wansheng Pharmaceutical Co. Ltd., and Yangtze River Pharmaceutical Group.

  10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/anastrozole-tablets-market-3818

  11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related